Trials / Conditions / Community-acquired Infection
Community-acquired Infection
6 registered clinical trials studyying Community-acquired Infection.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and NCT01961206 | Jian-cang Zhou M.D. | — |
| Terminated | A Study to Evaluate Single and Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects a NCT01495065 | GlaxoSmithKline | Phase 1 |
| Terminated | A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation NCT01702350 | GlaxoSmithKline | Phase 1 |
| Completed | GSK2251052 Mass Balance in Healthy Adult Subjects NCT01475695 | GlaxoSmithKline | Phase 1 |
| Completed | An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokineti NCT01267968 | GlaxoSmithKline | Phase 1 |
| Completed | Computerized Decision Support System for Antibiotic Treatment NCT00233376 | Rabin Medical Center | Phase 3 |